rizatriptan has been researched along with Substance Withdrawal Syndrome in 1 studies
rizatriptan: structure given in first source; RN given refers to benzoate
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsarava, Z | 1 |
| Fritsche, G | 1 |
| Muessig, M | 1 |
| Diener, HC | 1 |
| Limmroth, V | 1 |
1 trial available for rizatriptan and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Clinical features of withdrawal headache following overuse of triptans and other headache drugs.
Topics: Adult; Analgesics; Drug Therapy, Combination; Ergotamine; Female; Headache; Humans; Indoles; Male; M | 2001 |